IL5 and asthma: The unique task of interleukin (IL)-5 in producing, activating, and localizing eosinophils has led to speculation that it represents the next primary goal for therapeutic intervention in asthma, chronic obstructive pulmonary disease, and other eosinophilic diseases [9].